Symbols

CLSD(Delisted)

Clearside Biomedical·NASDAQ

--(--)

CLSD fundamentals

CLSD Q2 undefined Earnings

Clearside Biomedical (CLSD) released its earnings on Aug 9, 2017: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.

Revenue / YoY

EPS / YoY

Report date

Aug 9, 2017

Earnings

EPS

Revenue

Revenue & Expenses

CLSD has released its 2025 Q3 earnings report, with revenue of 201.00K, reflecting a YoY change of -80.64%, and net profit of -5.97M, showing a YoY change of 22.32%. The Sankey diagram below clearly presents CLSD's revenue sources and cost distribution.

Key Indicators

Clearside Biomedical (CLSD) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Clearside Biomedical (CLSD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Clearside Biomedical (CLSD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Clearside Biomedical (CLSD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown

Revenue Breakdown

Where does Clearside Biomedical (CLSD) generate its revenue? Explore its key revenue streams and top earning regions.

By Business

Data source:

By Region

Data source:

Dividend

Track Clearside Biomedical (CLSD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History

Payout Ratio

Dividend Yield

You can ask Aime

No Data